Urinary biomarkers of oxidative status.

[1]  L. Wagenknecht,et al.  Urinary F2‐Isoprostanes, Obesity, and Weight Gain in the IRAS Cohort , 2012, Obesity.

[2]  H. Sampath,et al.  Regulation of DNA glycosylases and their role in limiting disease , 2012, Free radical research.

[3]  F. Clavel-Chapelon,et al.  The Associations of Advanced Glycation End Products and Its Soluble Receptor with Pancreatic Cancer Risk: A Case–Control Study within the Prospective EPIC Cohort , 2012, Cancer Epidemiology, Biomarkers & Prevention.

[4]  Steffen Loft,et al.  Biologically relevant oxidants and terminology, classification and nomenclature of oxidatively generated damage to nucleobases and 2-deoxyribose in nucleic acids , 2012, Free radical research.

[5]  L. Wagenknecht,et al.  Urinary F2-Isoprostanes as a Biomarker of Reduced Risk of Type 2 Diabetes , 2011, Diabetes Care.

[6]  Dean P. Jones,et al.  Biomarkers of Oxidative Stress Study IV: ozone exposure of rats and its effect on antioxidants in plasma and bronchoalveolar lavage fluid. , 2011, Free radical biology & medicine.

[7]  M. Lagarde,et al.  Functional lipidomics of oxidized products from polyunsaturated fatty acids. , 2011, Chemistry and Physics of Lipids.

[8]  A. Soro-Paavonen,et al.  RAGE biology, atherosclerosis and diabetes. , 2011, Clinical science.

[9]  N. Rothman,et al.  Obesity, age, and oxidative stress in middle-aged and older women. , 2011, Antioxidants & redox signaling.

[10]  André M Deelder,et al.  Mild and selective labeling of malondialdehyde with 2-aminoacridone: assessment of urinary malondialdehyde levels. , 2011, The Analyst.

[11]  A. Sigurdson,et al.  Variation in base excision repair capacity. , 2011, Mutation research.

[12]  R. Silber,et al.  Prognostic Potential and Tumor Growth-Inhibiting Effect of Plasma Advanced Glycation End Products in Non-Small Cell Lung Carcinoma , 2011, Molecular medicine.

[13]  W. Atkins,et al.  Interactions of glutathione transferases with 4-hydroxynonenal , 2011, Drug metabolism reviews.

[14]  L. Jones,et al.  Effects of aerobic training on oxidative status in postsurgical non-small cell lung cancer patients: a pilot study. , 2011, Lung cancer.

[15]  S. Cummings,et al.  F2‐Isoprostanes and Adiposity in Older Adults , 2011, Obesity.

[16]  G. Münch,et al.  Advanced glycation endproducts as gerontotoxins and biomarkers for carbonyl-based degenerative processes in Alzheimer's disease , 2011, Clinical chemistry and laboratory medicine.

[17]  Michael J Morgan,et al.  Crosstalk of reactive oxygen species and NF-κB signaling , 2011, Cell Research.

[18]  H. Forman.  Reactive oxygen species and α,β‐unsaturated aldehydes as second messengers in signal transduction , 2010, Annals of the New York Academy of Sciences.

[19]  D. Millington,et al.  Allantoin in human urine quantified by ultra-performance liquid chromatography-tandem mass spectrometry. , 2010, Analytical biochemistry.

[20]  B. Halliwell,et al.  Using isoprostanes as biomarkers of oxidative stress: some rarely considered issues. , 2010, Antioxidants & redox signaling.

[21]  P. Marcom,et al.  Urinary Biomarkers of Oxidative Status in a Clinical Model of Oxidative Assault , 2010, Cancer Epidemiology, Biomarkers & Prevention.

[22]  D. Millington,et al.  Quantification of the oxidative damage biomarker 2,3-dinor-8-isoprostaglandin-F(2alpha) in human urine using liquid chromatography-tandem mass spectrometry. , 2010, Analytical biochemistry.

[23]  X. Shu,et al.  Intra-Person Variation of Urinary Biomarkers of Oxidative Stress and Inflammation , 2010, Cancer Epidemiology, Biomarkers & Prevention.

[24]  Jianling Xie,et al.  Trends in advanced glycation end products research in diabetes mellitus and its complications , 2010, Molecular and Cellular Biochemistry.

[25]  Trevor A. Mori,et al.  Measurement of urinary F2-isoprostanes by gas chromatography-mass spectrometry is confounded by interfering substances , 2010, Free radical research.

[26]  J. Marks,et al.  Individual responses to chemotherapy-induced oxidative stress , 2010, Breast Cancer Research and Treatment.

[27]  L. Jones,et al.  Quantification of Selected F2Isoprostanes and Creatinine in Human Urine by Liquid Chromatographyelectrospray Tandem Mass Spectrometry (LCESIMS/MS) , 2010 .

[28]  Heather C. Kuiper,et al.  Quantitation of mercapturic acid conjugates of 4-hydroxy-2-nonenal and 4-oxo-2-nonenal metabolites in a smoking cessation study. , 2010, Free radical biology & medicine.

[29]  D. Pelclova,et al.  Rapid and easy method for monitoring oxidative stress markers in body fluids of patients with asbestos or silica-induced lung diseases. , 2009, Journal of chromatography. B, Analytical technologies in the biomedical and life sciences.

[30]  P. Marcom,et al.  Markers of oxidative status in a clinical model of oxidative assault: a pilot study in human blood following doxorubicin administration , 2009, Biomarkers : biochemical indicators of exposure, response, and susceptibility to chemicals.

[31]  H. Yamato,et al.  Urea, the most abundant component in urine, cross-reacts with a commercial 8-OH-dG ELISA kit and contributes to overestimation of urinary 8-OH-dG. , 2009, Free radical biology & medicine.

[32]  M. Cooke.  A commentary on "Urea, the most abundant component in urine, cross-reacts with a commercial 8-OH-dG ELISA kit and contributes to overestimation of urinary 8-OH-dG". What is ELISA detecting? , 2009, Free radical biology & medicine.

[33]  B. Henderson,et al.  Association of Plasma Micronutrient Levels and Urinary Isoprostane with Risk of Lung Cancer: The Multiethnic Cohort Study , 2009, Cancer Epidemiology Biomarkers & Prevention.

[34]  B. Halliwell,et al.  Allantoin in human plasma, serum, and nasal-lining fluids as a biomarker of oxidative stress: avoiding artifacts and establishing real in vivo concentrations. , 2009, Antioxidants & redox signaling.

[35]  N. Rothman,et al.  Oxidative stress, obesity, and breast cancer risk: results from the Shanghai Women's Health Study. , 2009, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[36]  B. Henderson,et al.  Association of selenium, tocopherols, carotenoids, retinol, and 15-isoprostane F2t in serum or urine with prostate cancer risk: the multiethnic cohort , 2009, Cancer Causes & Control.

[37]  N. Brown,et al.  Simultaneous determination of uric acid metabolites allantoin, 6-aminouracil, and triuret in human urine using liquid chromatography-mass spectrometry. , 2009, Journal of chromatography. B, Analytical technologies in the biomedical and life sciences.

[38]  E. Lakatta,et al.  RAGE signaling in inflammation and arterial aging. , 2009, Frontiers in bioscience.

[39]  J. Nourooz-Zadeh.  Key issues in F2-isoprostane analysis. , 2008, Biochemical Society transactions.

[40]  S. Basu.  F2-isoprostanes in human health and diseases: from molecular mechanisms to clinical implications. , 2008, Antioxidants & redox signaling.

[41]  Steffen Loft,et al.  Measurement and Meaning of Oxidatively Modified DNA Lesions in Urine , 2008, Cancer Epidemiology Biomarkers & Prevention.

[42]  P. Vineis,et al.  Validation of biomarkers for the study of environmental carcinogens: a review , 2008, Biomarkers : biochemical indicators of exposure, response, and susceptibility to chemicals.

[43]  C. Harris,et al.  Inflammation and cancer: An ancient link with novel potentials , 2007, International journal of cancer.

[44]  G. Vita,et al.  RAGE‐NF‐κB pathway activation in response to oxidative stress in facioscapulohumeral muscular dystrophy , 2007 .

[45]  F. Guéraud,et al.  4-Hydroxynonenal in foodstuffs: heme concentration, fatty acid composition and freeze-drying are determining factors , 2007, Redox report : communications in free radical research.

[46]  S. Garcia,et al.  Rapid quantification of malondialdehyde in plasma by high performance liquid chromatography-visible detection. , 2007, Journal of pharmaceutical and biomedical analysis.

[47]  A. Berrebi,et al.  Development of an enzymatic DNA repair assay for molecular epidemiology studies: distribution of OGG activity in healthy individuals. , 2007, DNA repair.

[48]  I. M. Jones,et al.  Exploration of methods to identify polymorphisms associated with variation in DNA repair capacity phenotypes. , 2006, Mutation research.

[49]  C. Giulivi,et al.  Current analytical methods for the detection of dityrosine, a biomarker of oxidative stress, in biological samples. , 2007, Mass spectrometry reviews.

[50]  G. Vita,et al.  RAGE-NF-kappaB pathway activation in response to oxidative stress in facioscapulohumeral muscular dystrophy. , 2007, Acta neurologica Scandinavica.

[51]  K. Roszkowski,et al.  Severe oxidatively damaged DNA after cisplatin treatment of cancer patients , 2006, International journal of cancer.

[52]  M. Desai,et al.  Polymorphisms in Nucleotide Excision Repair Genes and DNA Repair Capacity Phenotype in Sisters Discordant for Breast Cancer , 2006, Cancer Epidemiology Biomarkers & Prevention.

[53]  J. Morrow,et al.  Intraindividual Variability of Plasma Antioxidants, Markers of Oxidative Stress, C-Reactive Protein, Cotinine, and Other Biomarkers , 2006, Epidemiology.

[54]  Steffen Loft,et al.  Prospective study of 8-oxo-7,8-dihydro-2'-deoxyguanosine excretion and the risk of lung cancer. , 2006, Carcinogenesis.

[55]  A. Pilger,et al.  8-Hydroxy-2′-deoxyguanosine as a marker of oxidative DNA damage related to occupational and environmental exposures , 2006, International archives of occupational and environmental health.

[56]  V. Mužáková,et al.  Monitoring of antioxidant properties of uric acid in humans for a consideration measuring of levels of allantoin in plasma by liquid chromatography. , 2006, Clinica chimica acta; international journal of clinical chemistry.

[57]  J. Bonventre,et al.  Release of Free F2-isoprostanes from Esterified Phospholipids Is Catalyzed by Intracellular and Plasma Platelet-activating Factor Acetylhydrolases* , 2006, Journal of Biological Chemistry.

[58]  C. Cunningham,et al.  Quantification of dinor, dihydro metabolites of F2-isoprostanes in urine by liquid chromatography/tandem mass spectrometry. , 2006, Analytical biochemistry.

[59]  H. Tsukahara,et al.  Evaluation of a urinary multi-parameter biomarker set for oxidative stress in children, adolescents and young adults , 2006, Free radical research.

[60]  R. Sinha,et al.  Urinary Malondialdehyde-Equivalents during ingestion of meat cooked at high or low temperatures , 1995, Lipids.

[61]  L. Mcgirr,et al.  Urinary malondialdehyde as an indicator of lipid peroxidation in the diet and in the tissues , 1984, Lipids.

[62]  J. Wal,et al.  Enzyme immunoassay for a urinary metabolite of 4-hydroxynonenal as a marker of lipid peroxidation. , 2006, Free radical biology & medicine.

[63]  C. Chow,et al.  An improved method for the measurement of malondialdehyde in biological samples , 2006, Lipids.

[64]  J. Kornhuber,et al.  Evaluation of oxidative stress measurements in obstructive sleep apnea syndrome , 2005, Journal of Neural Transmission.

[65]  G. Zalba,et al.  NADPH oxidase-mediated oxidative stress: genetic studies of the p22(phox) gene in hypertension. , 2005, Antioxidants & redox signaling.

[66]  M. Evans,et al.  DNA repair is responsible for the presence of oxidatively damaged DNA lesions in urine. , 2005, Mutation research.

[67]  B. Tomlinson,et al.  A study of the effect of oral glucose loading on plasma oxidant:antioxidant balance in normal subjects , 2005, European journal of nutrition.

[68]  D. H. Thiel,et al.  Biomarkers of oxidative stress study II: are oxidation products of lipids, proteins, and DNA markers of CCl4 poisoning? , 2005, Free radical biology & medicine.

[69]  B. Ames,et al.  Biomarkers of oxidative stress study III. Effects of the nonsteroidal anti-inflammatory agents indomethacin and meclofenamic acid on measurements of oxidative products of lipids in CCl4 poisoning. , 2005, Free radical biology & medicine.

[70]  A. Kong,et al.  Induction of phase I, II and III drug metabolism/transport by xenobiotics , 2005, Archives of pharmacal research.

[71]  V. Lee,et al.  Effects of vitamins C and E on oxidative stress markers and endothelial function in patients with systemic lupus erythematosus: a double blind, placebo controlled pilot study. , 2005, The Journal of rheumatology.

[72]  F. Violante,et al.  A method for routine quantitation of urinary 8-hydroxy-2'-deoxyguanosine based on solid-phase extraction and micro-high-performance liquid chromatography/electrospray ionization tandem mass spectrometry. , 2005, Rapid communications in mass spectrometry : RCM.

[73]  J. Cravedi,et al.  Dihydroxynonene mercapturic acid, a urinary metabolite of 4‐hydroxynonenal, as a biomarker of lipid peroxidation , 2005, BioFactors.

[74]  N. Vermeulen,et al.  Evaluation of a Multi-parameter Biomarker Set for Oxidative Damage in Man: Increased Urinary Excretion of Lipid, Protein and DNA Oxidation Products after One Hour of Exercise , 2004, Free radical research.

[75]  J. Morrow,et al.  Epidemiological marker for oxidant status: comparison of the ELISA and the gas chromatography/mass spectrometry assay for urine 2,3-dinor-5,6-dihydro-15-F2t-isoprostane. , 2004, Annals of epidemiology.

[76]  Yuan-TehLee,et al.  Ascorbate Supplement Reduces Oxidative Stress in Dyslipidemic Patients Undergoing Apheresis , 2004 .

[77]  B. Halliwell,et al.  Measuring reactive species and oxidative damage in vivo and in cell culture: how should you do it and what do the results mean? , 2004, British journal of pharmacology.

[78]  T. Ohishi,et al.  The Maillard protein cross-link pentosidine in urine from diabetic patients , 1993, Diabetologia.

[79]  H. Matsumaru,et al.  Quantitative determination of urinary 8‐hydroxy‐2′‐deoxyguanosine level in healthy Japanese volunteers , 2004, BioFactors.

[80]  K. Uchida,et al.  Nϵ-(3-Methylpyridinium)lysine, a Major Antigenic Adduct Generated in Acrolein-modified Protein* , 2003, Journal of Biological Chemistry.

[81]  C. Exley,et al.  Measurement by reversed-phase high-performance liquid chromatography of malondialdehyde in normal human urine following derivatisation with 2,4-dinitrophenylhydrazine. , 2003, Journal of chromatography. B, Analytical technologies in the biomedical and life sciences.

[82]  D. Malencik,et al.  Dityrosine as a product of oxidative stress and fluorescent probe , 2003, Amino Acids.

[83]  B. Tudek,et al.  Products of oxidative DNA damage and repair as possible biomarkers of susceptibility to lung cancer. , 2003, Cancer research.

[84]  R. Schaur,et al.  Basic aspects of the biochemical reactivity of 4-hydroxynonenal. , 2003, Molecular aspects of medicine.

[85]  K. Uchida.  Histidine and lysine as targets of oxidative modification , 2003, Amino Acids.

[86]  K. Davies,et al.  Tyrosine oxidation products: analysis and biological relevance , 2003, Amino Acids.

[87]  H. Tsukahara,et al.  Oxidative stress and altered antioxidant defenses in children with acute exacerbation of atopic dermatitis. , 2003, Life sciences.

[88]  E. Benjamin,et al.  Obesity and Systemic Oxidative Stress: Clinical Correlates of Oxidative Stress in The Framingham Study , 2003, Arteriosclerosis, thrombosis, and vascular biology.

[89]  Takeo Kato,et al.  Increased urinary levels of pentosidine, pyrraline and acrolein adduct in type 2 diabetes. , 2003, Endocrine journal.

[90]  J. Morrow,et al.  The isoprostanes: their role as an index of oxidant stress status in human pulmonary disease. , 2002, American journal of respiratory and critical care medicine.

[91]  H. Rüdiger,et al.  Urinary excretion of 8-hydroxy-2'-deoxyguanosine measured by high-performance liquid chromatography with electrochemical detection. , 2002, Journal of chromatography. B, Analytical technologies in the biomedical and life sciences.

[92]  T. Osawa,et al.  Thiolation of Protein-bound Carcinogenic Aldehyde , 2002, The Journal of Biological Chemistry.

[93]  H. Brismar,et al.  Role of oxidative stress in advanced glycation end product-induced mesangial cell activation. , 2002, Kidney international.

[94]  J. Heinecke.  Oxidized amino acids: culprits in human atherosclerosis and indicators of oxidative stress. , 2002, Free radical biology & medicine.

[95]  J Bangsbo,et al.  Allantoin formation and urate and glutathione exchange in human muscle during submaximal exercise. , 2001, Free radical biology & medicine.

[96]  R. Hotchkiss,et al.  NADPH oxidase of neutrophils elevates o,o'-dityrosine cross-links in proteins and urine during inflammation. , 2001, Archives of biochemistry and biophysics.

[97]  A. Schmidt,et al.  Activation of NADPH oxidase by AGE links oxidant stress to altered gene expression via RAGE. , 2001, American journal of physiology. Endocrinology and metabolism.

[98]  Alexander Pilger,et al.  Longitudinal study of urinary 8-hydroxy-2′-deoxyguanosine excretion in healthy adults , 2001, Free radical research.

[99]  K. Roszkowski,et al.  8-Oxo-7,8-dihydroguanine and 8-oxo-7,8-dihydro-2′-deoxyguanosine levels in human urine do not depend on diet , 2001, Free radical research.

[100]  D. O'Connor,et al.  Plasma Hydrogen Peroxide Production in Human Essential Hypertension: Role of Heredity, Gender, and Ethnicity , 2000, Hypertension.

[101]  C. Leeuwenburgh,et al.  Increased oxidative stress in kwashiorkor. , 2000, The Journal of pediatrics.

[102]  M. Obrenovich,et al.  Transition metal-catalyzed oxidation of ascorbate in human cataract extracts: possible role of advanced glycation end products. , 2000, Investigative ophthalmology & visual science.

[103]  L. Marnett,et al.  Xenobiotic-metabolizing Cytochromes P450 Convert Prostaglandin Endoperoxide to Hydroxyheptadecatrienoic Acid and the Mutagen, Malondialdehyde* , 2000, The Journal of Biological Chemistry.

[104]  Y. Kaneda,et al.  Normalizing mitochondrial superoxide production blocks three pathways of hyperglycaemic damage , 2000, Nature.

[105]  Dean P. Jones,et al.  Biomarkers of oxidative stress study: are plasma antioxidants markers of CCl(4) poisoning? , 2000, Free radical biology & medicine.

[106]  E. Anggard,et al.  Evaluation of the postprandial effects of a fast-food meal on human plasma F(2)-isoprostane levels. , 2000, Free radical biology & medicine.

[107]  J. Morrow,et al.  Measurement of F(2)-isoprostanes as an index of oxidative stress in vivo. , 2000, Free radical biology & medicine.

[108]  B. Halliwell,et al.  Measurement of plasma F2-isoprostanes as an index of lipid peroxidation does not appear to be confounded by diet , 2000, Free radical research.

[109]  Kayoko Kita,et al.  Is allantoin in serum and urine a useful indicator of exercise-induced oxidative stress in humans? , 2000, Free radical research.

[110]  J. Morrow.  THE ISOPROSTANES: THEIR QUANTIFICATION AS AN INDEX OF OXIDANT STRESS STATUS IN VIVO† , 2000, Drug metabolism reviews.

[111]  B. Gladen,et al.  Biomarkers of oxidative stress study: are plasma antioxidants markers of CCl(4) poisoning? , 2000, Free radical biology & medicine.

[112]  S. Métairon,et al.  Urinary isoprostane excretion is not confounded by the lipid content of the diet , 1999, FEBS letters.

[113]  J. Holloszy,et al.  Hydroxyl radical generation during exercise increases mitochondrial protein oxidation and levels of urinary dityrosine. , 1999, Free radical biology & medicine.

[114]  B. Tomlinson,et al.  Simultaneous measurement of allantoin and urate in plasma: analytical evaluation and potential clinical application in oxidant:antioxidant balance studies. , 1999, Clinical chemistry.

[115]  D. Wu,et al.  Quantitative determination of an extremely polar compound allantoin in human urine by LC-MS/MS based on the separation on a polymeric amino column. , 1999, Journal of pharmaceutical and biomedical analysis.

[116]  G. Gibson,et al.  Protein‐Bound Acrolein , 1999, Journal of neurochemistry.

[117]  J. Morrow,et al.  Mass spectrometric quantification of F2-isoprostanes in biological fluids and tissues as measure of oxidant stress. , 1999, Methods in enzymology.

[118]  R. Strange,et al.  The glutathione S-transferases: influence of polymorphism on cancer susceptibility. , 1999, IARC scientific publications.

[119]  J. Cravedi,et al.  Identification of novel urinary metabolites of the lipid peroxidation product 4-hydroxy-2-nonenal in rats. , 1998, Chemical research in toxicology.

[120]  L. Roberts,et al.  Measurement of lipid peroxidation. , 1998, Free radical research.

[121]  E. Niki,et al.  Protein-bound acrolein: potential markers for oxidative stress. , 1998, Proceedings of the National Academy of Sciences of the United States of America.

[122]  J. Cravedi,et al.  1,4-Dihydroxynonene mercapturic acid, the major end metabolite of exogenous 4-hydroxy-2-nonenal, is a physiological component of rat and human urine. , 1998, Chemical research in toxicology.

[123]  G. FitzGerald,et al.  Nomenclature of isoprostanes: a proposal. , 1997, Prostaglandins.

[124]  J. Witztum,et al.  Excess iron induces hepatic oxidative stress and transforming growth factor β1 in genetic hemochromatosis , 1997, Hepatology.

[125]  J. Morrow,et al.  A nomenclature system for the isoprostanes. , 1997, Prostaglandins.

[126]  J. Baynes,et al.  New biomarkers of Maillard reaction damage to proteins. , 1996, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.

[127]  L. Sayre,et al.  Structural definition of early lysine and histidine adduction chemistry of 4-hydroxynonenal. , 1995, Chemical research in toxicology.

[128]  J. Cravedi,et al.  Mercapturic acid conjugates as urinary end metabolites of the lipid peroxidation product 4-hydroxy-2-nonenal in the rat. , 1995, Chemical research in toxicology.

[129]  C. Cross,et al.  Aromatic hydroxylation and nitration of phenylalanine and tyrosine by peroxynitrite , 1994, FEBS letters.

[130]  K. Davies,et al.  Dityrosine: a marker for oxidatively modified proteins and selective proteolysis. , 1994, Methods in enzymology.

[131]  E. Stadtman,et al.  Immunochemical detection of 4-hydroxynonenal protein adducts in oxidized hepatocytes. , 1993, Proceedings of the National Academy of Sciences of the United States of America.

[132]  Wei Li,et al.  Dityrosine, a specific marker of oxidation, is synthesized by the myeloperoxidase-hydrogen peroxide system of human neutrophils and macrophages. , 1993, The Journal of biological chemistry.

[133]  H. Esterbauer,et al.  Studies on epitopes on low-density lipoprotein modified by 4-hydroxynonenal. Biochemical characterization and determination. , 1992, The Biochemical journal.

[134]  J. Baynes,et al.  Formation of pentosidine during nonenzymatic browning of proteins by glucose. Identification of glucose and other carbohydrates as possible precursors of pentosidine in vivo. , 1991, The Journal of biological chemistry.

[135]  J. Morrow,et al.  A series of prostaglandin F2-like compounds are produced in vivo in humans by a non-cyclooxygenase, free radical-catalyzed mechanism. , 1990, Proceedings of the National Academy of Sciences of the United States of America.

[136]  D. Janero,et al.  Malondialdehyde and thiobarbituric acid-reactivity as diagnostic indices of lipid peroxidation and peroxidative tissue injury. , 1990, Free radical biology & medicine.

[137]  B. Halliwell,et al.  Action of biologically-relevant oxidizing species upon uric acid. Identification of uric acid oxidation products. , 1990, Chemico-biological interactions.

[138]  D. Muzny,et al.  Urate oxidase: primary structure and evolutionary implications. , 1989, Proceedings of the National Academy of Sciences of the United States of America.

[139]  J. Baynes,et al.  The Amadori product on protein: structure and reactions. , 1989, Progress in clinical and biological research.

[140]  S. Rajagopalan,et al.  Adriamycin-induced free radical formation in the perfused rat heart: implications for cardiotoxicity. , 1988, Cancer research.

[141]  A. Cerami,et al.  Advanced glycosylation end products in tissue and the biochemical basis of diabetic complications. , 1988, The New England journal of medicine.

[142]  L. Piché,et al.  Identification of N-ɛ-(2-propenal)lysine as the main form of malondialdehyde in food digesta , 1988 .

[143]  B. Halliwell,et al.  Measurement of allantoin and uric acid in human body fluids. A potential index of free-radical reactions in vivo? , 1987, The Biochemical journal.

[144]  M. Hecker,et al.  Products, kinetics, and substrate specificity of homogeneous thromboxane synthase from human platelets: development of a novel enzyme assay. , 1987, Archives of biochemistry and biophysics.

[145]  W. Pryor.  Oxy-radicals and related species: their formation, lifetimes, and reactions. , 1986, Annual review of physiology.

[146]  B. Halliwell,et al.  Free radicals in biology and medicine , 1985 .

[147]  J. Zweier,et al.  Characterization of the cycle of iron-mediated electron transfer from Adriamycin to molecular oxygen. , 1985, The Journal of biological chemistry.

[148]  B. Ames,et al.  Uric acid provides an antioxidant defense in humans against oxidant- and radical-caused aging and cancer: a hypothesis. , 1981, Proceedings of the National Academy of Sciences of the United States of America.

[149]  A. Cerami,et al.  The biochemistry of the complications of diabetes mellitus. , 1981, Annual review of biochemistry.

[150]  S. K. Wadman,et al.  Nϵ-(carboxymethyd)lysine, a constituent of human urine , 1975 .

[151]  I. M. Neiman,et al.  [Inflammation and cancer]. , 1974, Patologicheskaia fiziologiia i eksperimental'naia terapiia.

[152]  E. Young,et al.  ON THE ESTIMATION OF ALLANTOIN BY THE RIMINI-SCHRYVER REACTION , 1942 .